Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
International Journal for Parasitology. Parasites and Wildlife|July 2, 2016
Seroprevalence of Borrelia burgdorferi antibodies in white-tailed deer from TexasShakirat A Adetunji, Rosina C Krecek, Gabrielle Castellanos, et al.
Vaccine|January 28, 2014
Efficacy of a recombinant Rift Valley fever virus MP-12 with NSm deletion as a vaccine candidate in sheepHana M Weingartl, Charles K Nfon, Shunzhen Zhang, et al.
Plos One|April 9, 2010
Rapid accumulation of virulent rift valley Fever virus in mice from an attenuated virus carrying a single nucleotide substitution in the m RNAJohn C Morrill, Tetsuro Ikegami, Naoko Yoshikawa-Iwata, et al.
Vaccine|September 3, 2013
Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calvesJohn C Morrill, Richard C Laughlin, Nandadeva Lokugamage, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 19, 2025
Surveillance for Serological Evidence of Bourbon and Heartland Virus Infection in White-Tailed Deer and Feral Swine in TexasKaren Valdez, Patricia V Aguilar, Diana Fernandez, et al.
The Onderstepoort Journal of Veterinary Research|March 8, 2019
Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from TanzaniaSalama Nyundo, Ester Adamson, Jessica Rowland, et al.
Vaccine|November 17, 2012
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheepJohn C Morrill, Richard C Laughlin, Nandadeva Lokugamage, et al.
Vaccine|December 27, 2015
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolatesPhillip R Pittman, Sarah L Norris, Elizabeth S Brown, et al.
Plos One|March 26, 2013
The nucleocapsid protein of Rift Valley fever virus is a potent human CD8+ T cell antigen and elicits memory responsesWeidong Xu, Douglas M Watts, Margaret C Costanzo, et al.
The American Journal of Tropical Medicine and Hygiene|September 19, 2022
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of DiseaseDouglas M Watts, Jonna L B Westover, Pedro M Palermo, et al.
Pageof 3